Diagnosis Code

R89.8 OTH ABNORMAL FINDINGS IN SPECIMENS FROM OTH ORG/TISS


Code Information

Diagnosis Code: R89.8

Short Description: Oth abnormal findings in specimens from oth org/tiss

Long Description: Other abnormal findings in specimens from other organs, systems and tissues

The code R89.8 is VALID for claim submission

Code Classification:

  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00–R99)
    • Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)
      • Abnormal findings in specimens from oth org/tiss (R89)
        • R89.8 Oth abnormal findings in specimens from oth org/tiss

Code Version: 2022 ICD-10-CM


Synonyms

  • Abnormal amino acid sequence
  • Abnormal amniotic fluid
  • Abnormal bone marrow iron
  • Abnormal carbohydrate sequence
  • Abnormal consistency
  • Abnormal macromolecular binding
  • Abnormal macromolecular sequence
  • Abnormal molecular cross-linking
  • Abnormal nucleic acid sequence
  • Abnormal nucleotide base sequence
  • Abnormal organ weight
  • Abnormal presence of galactose
  • Abnormal presence of glucose
  • Abnormal presence of hemoglobin
  • Abnormal presence of myoglobin
  • Abnormal presence of pentose
  • Abnormal presence of protein
  • Abnormal size
  • Abnormal structure of cerebroside
  • Abnormal structure of phospholipid
  • Abnormal structure of physiologic substance
  • Abnormal thickness
  • Abnormal translucency
  • Abnormally decreased organ weight
  • Abnormally hard consistency
  • Abnormally increased laxity
  • Abnormally increased organ weight
  • Abnormally soft consistency
  • Absent bone marrow iron
  • Acellular smear
  • Aceto-white reaction finding
  • Aceto-white reaction positive
  • Adenylic acid above reference range
  • Adenylic acid below reference range
  • Allelic exclusion
  • Alpha-fetoprotein above reference range
  • Alteration of genetic material
  • Amino acid above reference range
  • Amino acid below reference range
  • Amniotic fluid AFP - finding
  • Amniotic fluid AFP - finding
  • Amniotic fluid alpha-fetoprotein above reference range
  • Amniotic fluid alpha-fetoprotein outside reference range
  • Amniotic fluid volume below reference range
  • Ascorbic acid above reference range
  • Ascorbic acid below reference range
  • Beta amino isobutyric acid above reference range
  • Beta amino isobutyric acid below reference range
  • Bilirubin level - finding
  • Bilirubin level below reference range
  • Biliverdin above reference range
  • Bone marrow erythropoiesis - finding
  • Bone marrow erythropoiesis - finding
  • Bone marrow erythropoiesis - finding
  • Bone marrow erythropoiesis hyperplasia
  • Bone marrow iron finding
  • Bone marrow iron finding
  • Bone marrow megaloblastic
  • Bone marrow normoblastic
  • Breast cancer genetic marker of susceptibility detected
  • Calculus = bilirubin
  • Calculus = carbaptite
  • Calculus = cholesterol
  • Calculus = hydroxyapatite
  • Calculus = phosphate
  • Calculus = triple phosphate
  • Calculus chemical composition - finding
  • Cancer antigen 27-29 above reference range
  • Carbohydrate above reference range
  • Carbohydrate below reference range
  • Carbohydrate conformation
  • Cell chromosome examination abnormal
  • Cell division alteration
  • Cell division alteration
  • Cell division alteration
  • Cell division alteration
  • Cell division alteration
  • Cholesterol/high density lipoprotein ratio above reference range
  • Choline above reference range
  • Choline below reference range
  • Cold agglutinins detected
  • Contact sensitivity response - finding
  • Contraction
  • CYP2C19 rapid metabolizer
  • CYP2C9 poor metabolizer
  • CYP2C9 poor metabolizer
  • Cystine above reference range
  • Cystine below reference range
  • Cytochrome P450 family 1 subfamily A member 2 poor metabolizer
  • Cytochrome P450 family 1 subfamily A member 2 rapid metabolizer
  • Cytochrome P450 family 1 subfamily A member 2 ultra-rapid metabolizer
  • Cytochrome P450 family 2 subfamily C member 9 *2/*3 poor metabolizer
  • Cytochrome P450 family 2 subfamily C member 9 *3/*3 poor metabolizer
  • Cytochrome P450 family 2 subfamily C member 9 rapid metabolizer
  • Cytochrome P450 family 2 subfamily C member 9 ultra-rapid metabolizer
  • Cytochrome P450 family 2 subfamily D member 6 rapid metabolizer
  • Cytochrome P450 family 3 subfamily A member 4 poor metabolizer
  • Cytochrome P450 family 3 subfamily A member 4 rapid metabolizer
  • Cytochrome P450 family 3 subfamily A member 4 ultra-rapid metabolizer
  • Cytochrome P450 family 3 subfamily A member 5 ultra-rapid metabolizer
  • Cytochrome P450 family 4 subfamily F member 2 poor metabolizer
  • Decrease in circumference
  • Decreased cell mitotic activity
  • Decreased ceroid
  • Decreased diameter
  • Decreased macromolecular binding
  • Decreased molecular dissociation
  • Decreased size
  • Decreased thickness
  • Decreased translucency
  • Defective molecular assembly
  • Denaturation
  • Depolymerization
  • DNA damage
  • Down syndrome detected by multiple marker screening
  • Effect of antiestrogen agent
  • Extra chromosomal inheritance
  • Fetal anomaly present in specimen
  • Fetal tissue present in specimen
  • Fibrinogen below reference range
  • Finding by inspection
  • Finding by inspection
  • Finding of amniotic fluid volume
  • Finding of organ weight
  • Finding of organ weight
  • Finding of organ weight
  • Finding of oxygen saturation
  • Finding of vitamin B12 level
  • Finding related to physiologic substance
  • Finding related to physiologic substance
  • Finding related to physiologic substance
  • Finding related to physiologic substance
  • Folic acid above reference range
  • Folic acid below reference range
  • Frame-shift mutation
  • Fructose above reference range
  • Fructose below reference range
  • Galactose above reference range
  • Galactose below reference range
  • Gene amplification
  • Gene re-arrangement
  • Gene re-arrangement, alpha chain, T cell antigen receptor
  • Gene re-arrangement, B lymphocyte
  • Gene re-arrangement, B lymphocyte, heavy chain
  • Gene re-arrangement, B lymphocyte, light chain
  • Gene re-arrangement, beta chain, T cell antigen receptor
  • Gene re-arrangement, gamma chain, T cell antigen receptor
  • Gene re-arrangement, T lymphocyte
  • Genetic finding detected
  • Genetic inversion
  • Genetic linkage disequilibrium
  • Genetic linkage equilibrium
  • Genetic mosaic
  • Genetic mutation
  • Genetic susceptibility to cancer
  • Genetic susceptibility to genetic disorder
  • Genetic susceptibility to malignant hyperthermia due to calcium voltage-gated channel subunit alpha1 S gene mutation
  • Globulin below reference range
  • Glucose level above reference range
  • Glycogen above reference range
  • Glycogen below reference range
  • Granulocyte count below reference range
  • GU test finding
  • Heterozygous protocadherin 19 gene mutation detected
  • Histidine above reference range
  • Histidine below reference range
  • Homogentisic acid above reference range
  • Human epidermal growth factor receptor 2 gene amplification detected
  • Human papillomavirus deoxyribonucleic acid detected
  • Increase in circumference
  • Increased cell mitotic activity
  • Increased ceroid
  • Increased diameter
  • Increased macromolecular binding
  • Increased molecular dissociation
  • Increased nuchal translucency detected by multiple marker screening
  • Increased translucency
  • Inequality in circumference
  • Influenza A H1N1 virus 2009 pandemic strain present
  • Influenza A virus subtype H1 present
  • Karyotype evaluation abnormal
  • Keratin, type I cytoskeletal 19 fragment above reference range
  • Ketone bodies above reference range
  • Lactic acid level above reference range
  • Lactose above reference range
  • Lactose below reference range
  • Laxity
  • Macromolecular alteration
  • Macromolecular binding
  • Macromolecular cleavage
  • Macromolecular defective synthesis
  • Macromolecular nicking
  • Malignant hyperthermia genetic susceptibility
  • Mannoheptulose above reference range
  • Mannoheptulose below reference range
  • Measurement finding above reference range
  • Measurement finding below reference range
  • Meiotic alteration
  • Methemalbumin above reference range
  • Methemalbumin below reference range
  • Mitochondrial 1555 A to G mutation detected
  • Mitochondrial mutation
  • Mitotic alteration
  • Mitotic arrest
  • Molecular conformation
  • Molecular degradation
  • Molecular dissociation
  • Molecular inactivation
  • Molecular instability
  • Monocyte count - finding
  • Monocyte count outside reference range
  • Mucopurulent
  • N-acetyltransferase 2 slow acetylator
  • Needle shaped crystals present
  • Nonsense mutation
  • Nucleic acid conformation
  • Nucleotide base deletion
  • Orotic acid above reference range
  • Orotic acid below reference range
  • Oxygen saturation above reference range
  • Pentose above reference range
  • Pentose below reference range
  • Phosphate kidney stone
  • Point mutation
  • Porphyrin below reference range
  • Positive skin test reaction
  • Presence of crystals - finding
  • Presence of ova cysts and parasites - finding
  • Protein conformation
  • Protein electrophoresis outside reference range
  • Protein-bound iodine below reference range
  • Quantity of physiologic substance outside reference range
  • Retraction
  • Sample grossly hemolyzed
  • Sample grossly icteric
  • Sample grossly lipemic
  • Sample hemolyzed
  • Sample hemolyzed
  • Sample icteric
  • Sample icteric
  • Sample lipemic
  • Sample lipemic
  • Sample slightly hemolyzed
  • Sample slightly icteric
  • Sample slightly lipemic
  • Satisfactory for evaluation but limited by partially obscuring air drying artifact
  • Satisfactory for evaluation but limited by partially obscuring thick areas
  • Shrinkage
  • Snowstorm knee
  • Somatic mutation
  • Specific gravity - finding
  • Specific gravity above reference range
  • Specimen involvement by multifocal invasion
  • Specimen too thick for optimal interpretation
  • Strand breaks
  • Stringing of synovial fluid
  • Superhelicity
  • Suppressor mutation
  • Suture material present
  • Synovial fluid appearance - finding
  • Synovial fluid appearance - finding
  • Synovial fluid appearance - finding
  • Synovial fluid appearance - finding
  • Synovial fluid appearance - finding
  • Synovial fluid appearance - finding
  • Synovial fluid bloodstained
  • Synovial fluid cloudy
  • Synovial fluid composition - finding
  • Synovial fluid composition - finding
  • Synovial fluid composition - finding
  • Synovial fluid composition - finding
  • Synovial fluid composition - finding
  • Synovial fluid fibrin clot
  • Synovial fluid fibrin clot
  • Synovial fluid turbid
  • Synovial fluid viscosity - finding
  • Synovial fluid viscosity - finding
  • Synovial fluid viscosity high
  • Synovial fluid viscosity low
  • Synovial fluid yellow
  • Synovial fluid: abnormal content
  • Synovial fluid: abnormal content
  • Synovial fluid: abnormal content
  • Synovial fluid: crystals
  • Synovial fluid: fibrin clot +
  • Synovial fluid: pyrophosphate
  • Synovial fluid: uric acid
  • Temperature-sensitive mutation
  • Thyroid hormone level below reference range
  • Tissue specimen fragmented
  • Tissue specimen ruptured
  • Translucency finding
  • Translucency finding
  • Translucency finding
  • Trisomy 18 detected by multiple marker screening
  • Tumor protein p53 detected
  • Tyrosine above reference range
  • Tyrosine below reference range
  • Uncertain malignant hyperthermia predisposition due to RyR1 gene mutation
  • Uric acid level below reference range
  • Urobilin above reference range
  • Urobilin below reference range
  • Urobilinogen level above reference range
  • Urobilinogen level below reference range
  • Uroporphyrin below reference range
  • Vanillylmandelic acid level above reference range
  • Vanillylmandelic acid level below reference range
  • Vesicular reaction
  • Vitamin A above reference range
  • Vitamin B below reference range
  • Vitamin B12 above reference range
  • Vitamin D above reference range
  • Vitamin E above reference range
  • Vitamin K above reference range
  • Vitamin K epoxide reductase complex 1 poor metabolizer
  • Vitamin K epoxide reductase complex 1 rapid metabolizer
  • Vitamin K epoxide reductase complex 1 ultra-rapid metabolizer
  • Xanthine above reference range
  • Xanthine below reference range

Diagnostic Related Group(s)

The code R89.8 is grouped in the following Diagnostic Related Group(s) (MS-DRG v39.0)
  • Signs And Symptoms With Mcc (947)
  • Signs And Symptoms Without Mcc (948)

References to Index of Diseases and Injuries

The code R89.8 has the following ICD-10-CM references to the Index of Diseases and Injuries
  • Inclusion Terms:
    • Abnormal chromosomal findings in specimens from other organs, systems and tissues

Crosswalk Information

ICD-10 Code ICD-9 Code ICD-9 Description
R89.8 Right Arrow 792.9 Abn find-body subst NEC
795.2 Abn chromosomal analysis

This ICD-10 to ICD-9 data is based on the 2018 General Equivalency Mapping (GEM) files published by the Centers for Medicare & Medicaid Services (CMS) for informational purposes only. The data is not an ICD-10 conversion tool and doesn’t guarantee clinical accuracy.

Similar Codes

ICD-10 Code ICD-10 Description
R89 Abnormal findings in specimens from other organs, systems and tissues
R89.0 Abnormal level of enzymes in specimens from other organs, systems and tissues
R89.1 Abnormal level of hormones in specimens from other organs, systems and tissues
R89.2 Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues
R89.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues
R89.4 Abnormal immunological findings in specimens from other organs, systems and tissues
R89.5 Abnormal microbiological findings in specimens from other organs, systems and tissues
R89.6 Abnormal cytological findings in specimens from other organs, systems and tissues
R89.7 Abnormal histological findings in specimens from other organs, systems and tissues
R89.9 Unspecified abnormal finding in specimens from other organs, systems and tissues


This page was last updated on: 10/1/2023